Protalix BioTherapeutics (PLX) EPS (Diluted) (2011 - 2026)
Powered by 
Analysis
Protalix BioTherapeutics (PLX) EPS (Diluted) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.12 Bn | 192.13 Bn | 7.24 Bn | 4.37 |
| 2 | Gilead Sciences | 180.16 Bn | 176.98 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 131.52 Bn | 123.67 Bn | 2.84 Bn | 4.31 |
| 4 | Regeneron Pharmaceuticals | 81.95 Bn | 73.96 Bn | 3.93 Bn | 12.23 |
| 5 | Argenx Se | 60.36 Bn | 55.18 Bn | 1.37 Bn | 7.15 |
| 6 | Moderna | 53.81 Bn | 48.67 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.01 Bn | 29.70 Bn | 992.69 Mn | 1.19 |
| 8 | Biogen | 31.96 Bn | 30.67 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.25 Bn | 29.25 Bn | 1.16 Mn | -0.40 |
| 10 | Protalix BioTherapeutics | 217.16 Mn | 176.51 Mn | 12.13 Mn | 0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 0.22 |
| Dec 31, 2025 | -0.04 |
| Sep 30, 2025 | 0.03 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | -0.05 |
| Dec 31, 2024 | 0.14 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | -0.03 |
| Mar 31, 2024 | -0.06 |
| Dec 31, 2023 | 0.01 |
| Sep 30, 2023 | -0.02 |
| Jun 30, 2023 | 0.19 |
| Mar 31, 2023 | -0.05 |
| Dec 31, 2022 | -0.07 |
| Sep 30, 2022 | -0.07 |
| Jun 30, 2022 | -0.11 |
| Mar 31, 2022 | -0.05 |
| Dec 31, 2021 | -0.15 |
| Sep 30, 2021 | -0.09 |